free counter

The FTC is investigating Amazons deal to get One Medical

Amazons buyout of iRobot and One Medical might take longer than expected. In accordance with Politico and The Wall Street Journal, the Federal Trade Commission is reviewing both acquisitions. Announced inside a month of every other, the deals are valued at $1.7 billion and $3.9 billion, respectively, and also have the potential to reshape two markets simultaneously.

One Medical parent company 1Life Healthcare disclosed the FTC was investigating its proposed merger with Amazon on Friday, reports The Journal. That same day, Politico said the Commission had also begun overview of Amazons deal to get iRobot. Based on the outlet, a formal probe is probable given the detailed questions the FTC delivered to both companies. Amazon and iRobot are reportedly finding your way through a potentially lengthy [and] arduous investigation. One source Politico spoke to told the outlet the review is wide-ranging and seeks to find out if the offer would give Amazon an unfair advantage in the connected devices and retail markets.

At least, the FTC could easily delay Amazon from finalizing the deals by up to year. For Amazon, a worst-case scenario would involve lawsuits from the Commission. In the beginning of the year, NVIDIA abandoned its proposed $40 billion acquisition of ARM following the FTC sued to block the purchase over concerns it could stifle competition across a number of markets. Whatever comes next, Amazon wont have a straightforward road ahead. FTC Chair Lina Khan is really a well-known company critic. She rose to prominence in legal circles on the trunk of articlestitled Amazon’s Antitrust Paradox.

All products recommended by Engadget are selected by our editorial team, independent of our parent company. A few of our stories include affiliate links. In the event that you buy something through one of these brilliant links, we might earn a joint venture partner commission.

Read More

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker